Database : MEDLINE
Search on : Chiari-Frommel and Syndrome [Words]
References found : 116 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 12 go to page                         

  1 / 116 MEDLINE  
              next record last record
select
to print
Photocopy

[PMID]: 21515505
[Au] Autor:Dufton JA; Habeeb SY; Heran MK; Mikulis DJ; Islam O
[Ad] Address:Department of Diagnostic Radiology, Kingston General Hospital, Queen's University, Toronto, Ontario, Canada.
[Ti] Title:Posterior fossa measurements in patients with and without Chiari I malformation.
[So] Source:Can J Neurol Sci;38(3):452-5, 2011 May.
[Is] ISSN:0317-1671
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:PURPOSE: To determine if there is a correlation between cerebellar tonsillar descent in patients with and without Chiari I malformation and three skull morphometric measurements: clivus length, anteroposterior diameter of the foramen magnum, and Boogard's angle. METHODS: Cerebellar tonsillar descent, clivus length, anteroposterior diameter of the foramen magnum, and Boogard's angle were measured in mid-sagittal T1-weighted magnetic resonance images of 188 patients. The study included 81 patients with Chiari I malformations (CMI). Without identifiable pathology, 107 patients served as a comparison group. Two-sample t-tests were used to assess for significance. A Pearson correlation matrix was constructed to assess the strength of linear dependence between measured parameters for the study population. RESULTS: A negative correlation was found between tonsillar herniation and clivus length (r = -0.30, P < 0.001), while a positive correlation was found between tonsillar herniation and foramen magnum size (r = 0.15, P = 0.0431), and Boogard's angle (r = 0.23, P = 0.0014). Clivus length was shorter (P = 0.0009) in CMI patients (4.02 cm ± 0.45) than comparison patients (4.23 cm ± 0.42). In addition, the anteroposterior diameter of the foramen magnum was wider (P = 0.0412) (3.74 cm ± 0.40 compared to 3.63 ± 0.30) and Boogard's angle was larger (P = 0.0079) (123.58 degrees ± 8.27 compared to 120.62 degrees ± 6.79) with CMI. CONCLUSION: A greater degree of cerebellar tonsillar herniation is associated with a shorter clivus length, a wider anteroposterior diameter of foramen magnum, and a wider Boogard's angle.
[Mh] MeSH terms primary: Chiari-Frommel Syndrome/pathology
Foramen Magnum/pathology
[Mh] MeSH terms secundary: Adult
Aged
Female
Humans
Linear Models
Magnetic Resonance Imaging/methods
Male
Middle Aged
Retrospective Studies
Young Adult
[Pt] Publication type:COMPARATIVE STUDY; JOURNAL ARTICLE
[Em] Entry month:1108
[Cu] Class update date: 140730
[Lr] Last revision date:140730
[Js] Journal subset:IM
[Da] Date of entry for processing:110426
[St] Status:MEDLINE

  2 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 21513643
[Au] Autor:Sekula RF; Arnone GD; Crocker C; Aziz KM; Alperin N
[Ad] Address:Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. rsekula@wpahs.org
[Ti] Title:The pathogenesis of Chiari I malformation and syringomyelia.
[So] Source:Neurol Res;33(3):232-9, 2011 Apr.
[Is] ISSN:1743-1328
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:OBJECTIVE: The pathogeneses of Chiari malformation type I and syringomyelia are incompletely understood. In this article, the authors attempt to review the current theories on the pathogeneses of Chiari I malformation and syringomyelia. METHODS: A literature review for articles pertaining to Chiari I malformation or syringomyelia before August 2010 was conducted; in addition, the author's own experience in treating Chiari I malformation and syringomyelia is included. RESULTS: Chiari I malformation has been defined radiographically as cerebellar tonsillar herniation or ectopia 5 mm or greater below the foramen magnum. By this narrow definition, Chiari I malformation (i.e. cerebellar tonsillar herniation or ectopia 5 mm or greater below the foramen magnum) likely encompasses a heterogeneous grouping of disorders caused by different mechanisms. Molecular and genetic studies have been helpful in furthering our understanding of Chiari I malformation. CONCLUSION: A review of the pathogeneses of Chiari I malformation and syringomyelia is reported.
[Mh] MeSH terms primary: Chiari-Frommel Syndrome/etiology
Chiari-Frommel Syndrome/pathology
Syringomyelia/etiology
Syringomyelia/pathology
[Mh] MeSH terms secundary: Brain/pathology
Chiari-Frommel Syndrome/genetics
Female
Humans
Magnetic Resonance Imaging
Male
Syringomyelia/genetics
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1108
[Cu] Class update date: 110425
[Lr] Last revision date:110425
[Js] Journal subset:IM
[Da] Date of entry for processing:110426
[St] Status:MEDLINE
[do] DOI:10.1179/016164111X12962202723724

  3 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 21513642
[Au] Autor:Labuda R; Loth F; Slavin K
[Ad] Address:C&S Patient Education Foundation, Wexford, PA 15090, USA. director@conquerchiari.org
[Ti] Title:National Institutes of Health Chiari Research Conference: state of the research and new directions.
[So] Source:Neurol Res;33(3):227-31, 2011 Apr.
[Is] ISSN:1743-1328
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:OBJECTIVE: To establish the current Chiari knowledge base and develop recommendations for future research. METHODS: Chiari malformation: state of the research and new directions was a two-day, National Institutes of Health sponsored conference. The agenda included review presentations and working groups tasked with developing specific, achievable research recommendations. Content for both the review presentations and working groups was divided into six areas: pathophysiology, symptoms and diagnosis, engineering and imaging analysis, treatment, pediatric issues, and related conditions. RESULTS: The articles in this issue represent the knowledge base that was developed at the conference, plus subsequent literature reviews. There are significant gaps in the understanding of Chiari malformation, including a clinically relevant definition of Chiari, confusing terminology, subjective diagnostic criteria, and a well-accepted standard of care. These knowledge gaps are not surprising given the relative lack of Chiari research compared to similar neurological conditions and the preponderance of case reports in the published Chiari literature. The lack of understanding, and research, regarding Chiari translates directly into negative patient experiences and outcomes. CONCLUSIONS: Implementation of the recommendations developed at the conference would not only further expand the current understanding of the condition, but would likely have a significant, positive impact on patient experiences and outcomes.
[Mh] MeSH terms primary: Biomedical Research/trends
Chiari-Frommel Syndrome
Guidelines as Topic/standards
[Mh] MeSH terms secundary: Biomedical Research/organization & administration
Biomedical Research/standards
Chiari-Frommel Syndrome/pathology
Chiari-Frommel Syndrome/physiopathology
Chiari-Frommel Syndrome/therapy
Databases, Bibliographic/statistics & numerical data
Humans
National Institutes of Health (U.S.)
United States
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1108
[Cu] Class update date: 110425
[Lr] Last revision date:110425
[Js] Journal subset:IM
[Da] Date of entry for processing:110426
[St] Status:MEDLINE
[do] DOI:10.1179/016164111X12962202723689

  4 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 19736012
[Au] Autor:Furtado SV; Reddy K; Hegde AS
[Ad] Address:Department of Neurosurgery, Sri Satya Sai Institute of Higher Medical Sciences, EPIP Area, Whitefield, Bangalore 560 066, Karnataka, India. sunilvf@gmail.com
[Ti] Title:Posterior fossa morphometry in symptomatic pediatric and adult Chiari I malformation.
[So] Source:J Clin Neurosci;16(11):1449-54, 2009 Nov.
[Is] ISSN:1532-2653
[Cp] Country of publication:Scotland
[La] Language:eng
[Ab] Abstract:The linear dimensions and volume of the posterior fossa, and the length of the supra-occiput and the clivus in children with Chiari I malformations (CMI) were studied. A statistical relationship between patient demographics, radiological features, posterior fossa and occipital bone morphometry in the study and control groups was investigated. The results of 21 pediatric patients was compared to those of a matched control group. The posterior fossa volume (PFV) of an adult CMI group was also studied. Linear measurements were used to calculate the length of the occipital bone, spherical PFV and intracranial volume (ICV) using pre-operative MRI and CT scans. A PFV to ICV ratio was obtained to standardize the comparison. The volumetric measurement in the pediatric study group was also compared to the adult CMI group. The antero-posterior dimension, width, and volume of the posterior fossa and the PFV to ICV ratio in pediatric CMI patients was significantly lower than in the control group (p<0.05). There was no statistical difference in the length of the clivus and the supra-occiput between the two pediatric groups. The difference in the PFV to ICV ratio between pediatric and adult CMI patients was not statistically significant. Thus, the authors provide a simple, yet accurate, and reproducible method of comparison of posterior fossa volume in patients with CMI in different age groups, based on linear measurements. There is no significant difference between the length of the occipital bone at the base of the skull in pediatric CMI patients and the normal pediatric population. Development of the clivus due to late fusion of the sphenoid and occipital synchondroses in the second decade could result in manifestation of the disease in adulthood in CMI patients who were asymptomatic as children.
[Mh] MeSH terms primary: Chiari-Frommel Syndrome/pathology
Chiari-Frommel Syndrome/physiopathology
Cranial Fossa, Posterior/pathology
[Mh] MeSH terms secundary: Adolescent
Cephalometry/methods
Chiari-Frommel Syndrome/diagnostic imaging
Child
Child, Preschool
Cranial Fossa, Posterior/diagnostic imaging
Cranial Fossa, Posterior/growth & development
Female
Humans
Magnetic Resonance Imaging/methods
Male
Pediatrics
Reference Values
Retrospective Studies
Spinal Cord/diagnostic imaging
Spinal Cord/pathology
Tomography, X-Ray Computed/methods
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:0912
[Cu] Class update date: 161125
[Lr] Last revision date:161125
[Js] Journal subset:IM
[Da] Date of entry for processing:090909
[St] Status:MEDLINE
[do] DOI:10.1016/j.jocn.2009.04.005

  5 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 16817441
[Au] Autor:Sengoku K
[Ad] Address:Department of Obstetrics and Gynecology, Asahikawa Medical College.
[Ti] Title:[Galactorrhea].
[So] Source:Nihon Rinsho;Suppl 2:458-61, 2006 Jun 28.
[Is] ISSN:0047-1852
[Cp] Country of publication:Japan
[La] Language:jpn
[Mh] MeSH terms primary: Galactorrhea
[Mh] MeSH terms secundary: Chiari-Frommel Syndrome/therapy
Diagnosis, Differential
Dopamine Agonists/therapeutic use
Female
Galactorrhea/diagnosis
Galactorrhea/etiology
Galactorrhea/physiopathology
Galactorrhea/therapy
Humans
Hyperprolactinemia/etiology
Hypothalamic Diseases/complications
Hypothalamic Diseases/physiopathology
Hypothalamic Diseases/therapy
Hypothyroidism/complications
Hypothyroidism/therapy
Prognosis
Prolactin/physiology
Prolactin/secretion
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:0 (Dopamine Agonists); 9002-62-4 (Prolactin)
[Em] Entry month:0609
[Cu] Class update date: 110727
[Lr] Last revision date:110727
[Js] Journal subset:IM
[Da] Date of entry for processing:060705
[St] Status:MEDLINE

  6 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 16776114
[Au] Autor:Iura T; Makinoda S; Neyatani N
[Ad] Address:Department of Obstetrics and Gynecology, Kanazawa Medical University.
[Ti] Title:[Chiari-Frommel syndrome].
[So] Source:Nihon Rinsho;Suppl 1:147-50, 2006 May 28.
[Is] ISSN:0047-1852
[Cp] Country of publication:Japan
[La] Language:jpn
[Mh] MeSH terms primary: Chiari-Frommel Syndrome
[Mh] MeSH terms secundary: Bromocriptine/administration & dosage
Chiari-Frommel Syndrome/diagnosis
Chiari-Frommel Syndrome/drug therapy
Chiari-Frommel Syndrome/etiology
Chiari-Frommel Syndrome/physiopathology
Diagnosis, Differential
Female
Humans
Hyperprolactinemia/drug therapy
Hyperprolactinemia/etiology
Prognosis
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Nm] Name of substance:3A64E3G5ZO (Bromocriptine)
[Em] Entry month:0608
[Cu] Class update date: 131121
[Lr] Last revision date:131121
[Js] Journal subset:IM
[Da] Date of entry for processing:060617
[St] Status:MEDLINE

  7 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 14657997
[Au] Autor:Tubbs RS; Oakes WJ
[Ti] Title:Pierre-Robin syndrome associated with Chiari I malformation.
[So] Source:Childs Nerv Syst;20(1):1-2; author reply 5-7, 2004 Jan.
[Is] ISSN:0256-7040
[Cp] Country of publication:Germany
[La] Language:eng
[Mh] MeSH terms primary: Chiari-Frommel Syndrome/complications
Pierre Robin Syndrome/complications
[Mh] MeSH terms secundary: Cleft Palate/pathology
Humans
Tongue/abnormalities
[Pt] Publication type:COMMENT; LETTER
[Em] Entry month:0404
[Cu] Class update date: 170926
[Lr] Last revision date:170926
[Js] Journal subset:IM
[Da] Date of entry for processing:031206
[St] Status:MEDLINE

  8 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 7704753
[Au] Autor:Kleinberg DL
[Ad] Address:New York University School of Medicine, New York.
[Ti] Title:Galactorrhea.
[So] Source:Curr Ther Endocrinol Metab;5:360-4, 1994.
[Is] ISSN:0831-652X
[Cp] Country of publication:Canada
[La] Language:eng
[Mh] MeSH terms primary: Galactorrhea/etiology
Galactorrhea/physiopathology
[Mh] MeSH terms secundary: Butyrophenones/adverse effects
Chiari-Frommel Syndrome/physiopathology
Chiari-Frommel Syndrome/therapy
Contraceptives, Oral/adverse effects
Female
Galactorrhea/therapy
Humans
Male
Menstruation
Phenothiazines/adverse effects
Pituitary Neoplasms/complications
Pituitary Neoplasms/physiopathology
[Pt] Publication type:JOURNAL ARTICLE
[Nm] Name of substance:0 (Butyrophenones); 0 (Contraceptives, Oral); 0 (Phenothiazines); GS9EX7QNU6 (phenothiazine)
[Em] Entry month:9505
[Cu] Class update date: 121115
[Lr] Last revision date:121115
[Js] Journal subset:IM
[Da] Date of entry for processing:940101
[St] Status:MEDLINE

  9 / 116 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 7757558
[Au] Autor:Aono T
[Ad] Address:Department of Obstetrics and Gynecology, School of Medicine, University of Tokushima.
[Ti] Title:[Chiari-Frommel's syndrome].
[So] Source:Ryoikibetsu Shokogun Shirizu;(1):20-2, 1993.
[Cp] Country of publication:Japan
[La] Language:jpn
[Mh] MeSH terms primary: Chiari-Frommel Syndrome
[Mh] MeSH terms secundary: Female
Humans
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:9506
[Cu] Class update date: 051116
[Lr] Last revision date:051116
[Js] Journal subset:IM
[Da] Date of entry for processing:930101
[St] Status:MEDLINE

  10 / 116 MEDLINE  
              first record previous record
select
to print
Photocopy

[PMID]: 3132404
[Au] Autor:Imai T; Yasuda K; Miura K
[Ad] Address:Third Department of Internal Medicine, Gifu University School of Medicine, Japan.
[Ti] Title:[Study on galactorrhea-amenorrhea syndrome (GAS) with special reference to normoprolactinemic GAS].
[So] Source:Nihon Naibunpi Gakkai Zasshi;64(1):1-15, 1988 Jan 20.
[Is] ISSN:0029-0661
[Cp] Country of publication:Japan
[La] Language:jpn
[Ab] Abstract:In order to clarify the mechanism(s) which causes galactorrhea and amenorrhea in patients with Galactorrhea-Amenorrhea Syndrome (GAS) (Group A, n = 20), composed of Chiari-Frommel Syndrome (CFS) (Subgroup I, n = 3), Argonz-del Castillo Syndrome (ADCS) (Subgroup II, n = 5) and Drug-induced Galactorrhea-Amenorrhea (DIG) (Subgroup III, n = 12), we analysed basal plasma prolactin (PRL) and gonadotropin levels and their responsiveness to TRH and LH-RH, respectively in GAS patients. In addition, another group of galactorrhea patients without amenorrhea (Group B, n = 29) was selected, and further divided into three subgroups; subgroup I (n = 7) with persisting postpartum lactation, subgroup II (n = 7) of idiopathic galactorrhea, and subgroup III (n = 15) induced by drug administration. There were found unexpectedly high frequencies of normoprolactinemic patients (less than 23.7 ng/ml) in 40% of GAS (66.7% in CFS, 40% in ADCS, and 33.3% in DIG). The PRL responsiveness to TRH, evaluated by % delta PRL (peak PRL - basal PRL/basal PRL X 100), tended to be high in ADCS and DIG (group after discontinuation of drugs) compared with those of normal subjects (n = 12) and patients with primary hypothyroidism (n = 21). PRL response was almost normal in CFS or DIG (group during drug administration). Basal level of plasma gonadotropin in GAS was comparable to that of normal subjects. However, responsiveness of gonadotropin to LH-RH in GAS tended to be high compared with that of normal subjects. The patients in group B (subgroup I-III) demonstrated almost parallel responses of PRL and gonadotropin, respectively, to those of corresponded subgroups in group A. From the present results, we concluded that; 1) It seems likely that frequency of normoprolactinemic patients in GAS (Group A) is surprisingly high. 2) A still unclarified mechanism(s) for the occurrence of galactorrhea, not explained solely by plasma radioimmunoassayable PRL level and/or hyperresponsiveness of PRL to stimuli, may operate on a considerably large number of group A patients. 3) Decreased gonadotropin secretion at pituitary level seems not to be a main cause of menstrual abnormality in group A patients. 4) The same mechanism(s) as in group A patients may cause galactorrhea in group B patients.
[Mh] MeSH terms primary: Amenorrhea/physiopathology
Galactorrhea/physiopathology
Lactation Disorders/physiopathology
Prolactin/blood
[Mh] MeSH terms secundary: Adolescent
Adult
Amenorrhea/blood
Chiari-Frommel Syndrome/blood
Chiari-Frommel Syndrome/physiopathology
Female
Galactorrhea/blood
Gonadotropin-Releasing Hormone
Gonadotropins, Pituitary/blood
Humans
Middle Aged
Pregnancy
Syndrome
Thyrotropin-Releasing Hormone
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Gonadotropins, Pituitary); 33515-09-2 (Gonadotropin-Releasing Hormone); 5Y5F15120W (Thyrotropin-Releasing Hormone); 9002-62-4 (Prolactin)
[Em] Entry month:8807
[Cu] Class update date: 151119
[Lr] Last revision date:151119
[Js] Journal subset:IM
[Da] Date of entry for processing:880120
[St] Status:MEDLINE


page 1 of 12 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information